Rafferty Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-39,187
| Closed | -$7.2M | – | 1332 |
|
|
2021
Q2 | $7.2M | Sell |
39,187
-10,729
| -21% | -$1.84M | 0.05% | 233 |
|
|
2021
Q1 | $7.63M | Buy |
49,916
+14,615
| +41% | +$2.26M | 0.05% | 206 |
|
|
2020
Q4 | $5.51M | Sell |
35,301
-12,299
| -26% | -$1.58M | 0.05% | 199 |
|
|
2020
Q3 | $5.45M | Buy |
47,600
+9,878
| +26% | +$1.07M | 0.07% | 168 |
|
|
2020
Q2 | $4.23M | Buy |
37,722
+9,381
| +33% | +$996K | 0.06% | 197 |
|
|
2020
Q1 | $2.54M | Sell |
28,341
-35,197
| -55% | -$3.45M | 0.11% | 112 |
|
|
2019
Q4 | $6.87M | Sell |
63,538
-17,212
| -21% | -$1.84M | 0.11% | 106 |
|
|
2019
Q3 | $7.91M | Buy |
80,750
+19,309
| +31% | +$2.18M | 0.12% | 91 |
|
|
2019
Q2 | $8.05M | Buy |
61,441
+7,144
| +13% | +$921K | 0.14% | 87 |
|
|
2019
Q1 | $7.34M | Buy |
54,297
+37,827
| +230% | +$4.7M | 0.12% | 90 |
|
|
2018
Q4 | $1.6M | Buy |
16,470
+173
| +1% | +$20.4K | 0.04% | 275 |
|
|
2018
Q3 | $2.27M | Sell |
16,297
-5,138
| -24% | -$645K | 0.04% | 248 |
|
|
2018
Q2 | $2.66M | Buy |
21,435
+7,952
| +59% | +$929K | 0.04% | 218 |
|
|
2018
Q1 | $1.5M | Buy |
13,483
+642
| +5% | +$76.7K | 0.02% | 393 |
|
|
2017
Q4 | $1.54M | Buy |
12,841
+2,181
| +20% | +$266K | 0.03% | 311 |
|
|
2017
Q3 | $1.5M | Sell |
10,660
-1,884
| -15% | -$256K | 0.03% | 326 |
|
|
2017
Q2 | $1.53M | Buy |
12,544
+3,126
| +33% | +$364K | 0.04% | 251 |
|
|
2017
Q1 | $1.14M | Buy |
9,418
+1,030
| +12% | +$133K | 0.03% | 319 |
|
|
2016
Q4 | $1.03M | Buy |
8,388
+2,804
| +50% | +$343K | 0.05% | 174 |
|
|
2016
Q3 | $684K | Buy |
5,584
+889
| +19% | +$114K | 0.03% | 281 |
|
|
2016
Q2 | $548K | Sell |
4,695
-1,368
| -23% | -$194K | 0.04% | 379 |
|
|
2016
Q1 | $844K | Buy |
6,063
+1,378
| +29% | +$202K | 0.05% | 266 |
|
|
2015
Q4 | $896K | Sell |
4,685
-459
| -9% | -$80.2K | 0.11% | 225 |
|
|
2015
Q3 | $804K | Buy |
5,144
+42
| +0.8% | +$7.66K | 0.06% | 276 |
|
|
2015
Q2 | $922K | Buy |
5,102
+326
| +7% | +$56.3K | 0.06% | 237 |
|
|
2015
Q1 | $828K | Buy |
4,776
+2,009
| +73% | +$364K | 0.06% | 267 |
|
|
2014
Q4 | $512K | Buy |
2,767
+701
| +34% | +$130K | 0.12% | 193 |
|
|
2014
Q3 | $343K | Buy |
+2,066
| New | +$339K | 0.04% | 230 |
|
|
2014
Q2 | – | Sell |
-2,687
| Closed | -$409K | – | 411 |
|
|
2014
Q1 | $409K | Buy |
2,687
+596
| +29% | +$94.8K | 0.08% | 108 |
|
|
2013
Q4 | $278K | Buy |
+2,091
| New | +$251K | 0.07% | 193 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM